
NATUS MEDICAL INC FREE
Get a free copy of the research report on Natus Medical (NTUS).It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. The firm has a market cap of $1.14 billion, a P/E ratio of 89.08 and a beta of 0.22. Natus Medical Incorporated has a one year low of $20.90 and a one year high of $33.93. The firm’s 50 day moving average price is $32.67 and its 200-day moving average price is $29.97. Shares of NTUS stock opened at $32.96 on Monday. Hedge funds and other institutional investors own 92.35% of the company’s stock. now owns 13,660 shares of the company’s stock worth $359,000 after acquiring an additional 1,125 shares during the last quarter.

lifted its holdings in shares of Natus Medical by 9.0% in the 1st quarter. New York State Teachers Retirement System now owns 77,157 shares of the company’s stock worth $2,028,000 after acquiring an additional 798 shares during the last quarter. New York State Teachers Retirement System lifted its holdings in shares of Natus Medical by 1.0% in the 1st quarter. DAFNA Capital Management LLC now owns 190,635 shares of the company’s stock worth $4,524,000 after acquiring an additional 94,982 shares during the last quarter. DAFNA Capital Management LLC lifted its holdings in shares of Natus Medical by 99.3% in the 4th quarter. now owns 88,752 shares of the company’s stock valued at $2,106,000 after buying an additional 10,083 shares during the period. grew its stake in shares of Natus Medical by 12.8% in the 4th quarter.

SG Americas Securities LLC purchased a new stake in Natus Medical during the 1st quarter valued at about $106,000. Other large investors also recently bought and sold shares of the company. Envestnet Asset Management Inc.’s holdings in Natus Medical were worth $1,438,000 at the end of the most recent reporting period. The fund owned 54,721 shares of the company’s stock after acquiring an additional 13,386 shares during the quarter. boosted its holdings in shares of Natus Medical Incorporated ( NASDAQ:NTUS – Get Rating) by 32.4% in the 1st quarter, Holdings Channel reports.
